Skip to main content
OpenTrials
Completed

NCT Number: NCT05148936

Communities Fighting COVID-19!

To create and evaluate effective COVID-19 testing uptake strategies that focus on underserved individuals who are exposed but have not accessed testing, and underserved individuals who are not routinely tested because they are unaware of their exposure or risk status in order to increase testing among these populations and reduce Covid-19 related disparities.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

6 year–120 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Contact Households

San Diego, California, 92182, United States

About this study

Communities Fighting COVID is a partnership between San Diego State's School of Public Health and numerous communities in San Diego focused on providing community-based testing to specific language-speaking communities and vulnerable populations. This partnership is funded by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics-Undeserved Populations (Radx-UP), with the aim of ensuring all Americans have access to timely COVID-19 testing and diagnosis. Many communities, particularly immigrant and people of color communities, have a harder time accessing existing COVID-19 resources due to transportation, language barriers, or other barriers.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • African American, Arabic speaking, Filipino, and Latino/a populations

Exclusion criteria

  • Younger than 6, not in focus populations

Treatment and study plan

COVID-19 Testing Home-based (Aim 1)

Other

Implementation of Antigen and PCR testing at participant homes

COVID-19 Testing Mobile (Aim 1)

Other

Implementation of Antigen and PCR testing at mobile test sites

COVID-19 Testing Mobile Approach 1 (Aim 2)

Other

Implementation of Antigen and PCR testing at mobile test sites - active outreach

COVID-19 Testing Mobile Approach 2 (Aim 2)

Other

Implementation of Antigen and PCR testing at mobile test sites - baseline outreach

Primary outcomes

  1. Test uptake

    Time frame: Through study completion, expected to be 20 months

    Testing volume by study arm as cumulative count per hours testing site operated

Secondary outcomes

  1. Test access

    Time frame: Through study completion, expected to be 20 months

    Proportion of individuals by study arm who note that this strategy has facilitated ability to test.

  2. Test Impact (COVID-19 diagnoses)

    Time frame: Through study completion, expected to be 20 months

    Proportion of COVID-19 diagnoses of those tested by study arm

  3. Test Impact (number needed to screen)

    Time frame: Through study completion, expected to be 20 months

    Number needed to screen (number tested in order to detect one new infection).

Sponsors and collaborators

Lead sponsor

San Diego State University

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Communities Fighting COVID!

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Dec 8, 2021
Registry last updated
Jun 14, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.